Trials / Completed
CompletedNCT00187252
Mascot Study: Management of Atrial Fibrillation (AF) Suppression in AF-Heart Failure (HF) COmorbidity Therapy
Management of Atrial Fibrillation Suppression in AF-HF COmorbidity Therapy
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 380 (estimated)
- Sponsor
- Abbott Medical Devices · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to evaluate whether adding AF Suppression™ to cardiac resynchronization therapy (CRT) improves the prognosis of heart failure patients benefiting from cardiac resynchronization therapy.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Atrial Overdrive Pacing | Pacemaker/ ICD implant |
Timeline
- Start date
- 2003-09-01
- Primary completion
- 2008-06-01
- Completion
- 2008-06-01
- First posted
- 2005-09-16
- Last updated
- 2019-02-04
Locations
1 site across 1 country: Italy
Source: ClinicalTrials.gov record NCT00187252. Inclusion in this directory is not an endorsement.